NYSEMKT: YCBDCbdmd Inc Stock Ownership - Who owns Cbdmd?
Insider buying vs selling
Have Cbdmd Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas Ronan Kennedy | Interim CEO and CFO | 2023-05-03 | 5,000 | $2.10 | $10.50kBuy |
YCBD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when YCBD insiders and whales buy or sell their stock.
YCBD Shareholders
What type of owners hold Cbdmd Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Raymond Scott Coffman | 971.99% | 29,598,118 | $29.60M | Insider |
| Martin A. Sumichrast | 185.29% | 5,642,388 | $5.64M | Insider |
| William F. Raines Iii | 75.18% | 2,289,338 | $2.29M | Insider |
| Caryn Nicole Dunayer | 42.49% | 1,293,890 | $1.29M | Insider |
| Peter J. Ghiloni | 10.18% | 310,000 | $310.00k | Insider |
| John J. Wiesehan Iii | 5.79% | 176,450 | $176.45k | Insider |
| Anthony Kennedy Shriver | 4.19% | 127,500 | $127.50k | Insider |
| Axs Investments LLC | 3.00% | 91,204 | $91.20k | Institution |
| Mark S. Elliott | 1.70% | 51,680 | $51.68k | Insider |
| Renaissance Technologies LLC | 1.03% | 31,311 | $31.31k | Institution |
YCBD vs Pharmaceutical Stocks
Cbdmd Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.